738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors

Abstract

BackgroundCLDN18.2 is a tight junction protein found in differentiated gastric epithelial cells which can become abnormally or ectopically expressed in a number of solid tumor indications. This exposure profile illustrates...